Biogen

Junghae Suh, Ph.D., VP, Head of Gene Therapy Accelerator Unit

Cambridge, MA

(NASDAQ: BIIB)

Virtual Presentation

At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases. 

www.biogen.com



By using this website you agree to accept our Privacy Policy and Terms & Conditions